Tonix Pharmaceuticals SG&A Expense (Quarterly) Analysis

Tonix Pharmaceuticals Holding Corp (TNXP)

0.1835 +0.01 (+7.25%) USD | NASDAQ | May 03, 16:00

0.1723 -0.01 (-6.10%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2008. Upgrade now.

Date	Value
December 31, 2023	11.62M
September 30, 2023	8.712M
June 30, 2023	7.026M
March 31, 2023	7.391M
December 31, 2022	8.054M
September 30, 2022	7.39M
June 30, 2022	6.757M
March 31, 2022	8.014M
December 31, 2021	7.183M
September 30, 2021	5.453M
June 30, 2021	5.429M
March 31, 2021	5.409M
December 31, 2020	4.926M
September 30, 2020	3.186M
June 30, 2020	3.621M
March 31, 2020	2.621M
December 31, 2019	3.044M
September 30, 2019	2.839M
June 30, 2019	2.352M
March 31, 2019	2.401M
December 31, 2018	2.593M
September 30, 2018	2.277M
June 30, 2018	2.076M
March 31, 2018	1.818M
December 31, 2017	1.909M

Date	Value
September 30, 2017	1.927M
June 30, 2017	2.016M
March 31, 2017	2.097M
December 31, 2016	2.63M
September 30, 2016	2.143M
June 30, 2016	2.32M
March 31, 2016	3.343M
December 31, 2015	3.912M
September 30, 2015	2.966M
June 30, 2015	2.913M
March 31, 2015	2.867M
December 31, 2014	3.229M
September 30, 2014	2.217M
June 30, 2014	1.974M
March 31, 2014	1.619M
December 31, 2013	2.381M
September 30, 2013	1.455M
June 30, 2013	1.142M
March 31, 2013	1.26M
December 31, 2012	1.216M
September 30, 2012	1.076M
June 30, 2012	1.023M
March 31, 2012	0.7627M
December 31, 2011	0.9709M
September 30, 2011	0.5225M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.352M

Minimum

Jun 2019

11.62M

Maximum

Dec 2023

5.844M

Average

5.453M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks